Zobrazeno 1 - 10
of 10
pro vyhledávání: '"S. S. Cathapermal"'
Autor:
M. L. Foegh, Vaclav Hampl, E. J. Sidney, Daniel P. Nelson, S. S. Cathapermal, Stephen L. Archer, Edward K Weir
Publikováno v:
Experimental Biology and Medicine. 213:43-49
Angiopeptin is an analog of somatostatin-14, which has been found to inhibit cellular proliferation in several models of systemic vascular injury. As proliferation plays a major role in pulmonary hypertension, we examined the hypothesis that angiopep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cee81fc5d81476f7ecbf16edc0d0816d
https://doi.org/10.3181/00379727-213-44034
https://doi.org/10.3181/00379727-213-44034
Autor:
Marie L. Foegh, S. S. Cathapermal, P. W. Ramwell, B. J. Matthews, K. S. Stark, Mun K. Hong, Kenneth M. Kent, Tahira Bhatti
Publikováno v:
Circulation. 88(2)
BACKGROUND Angiopeptin, a synthetic somatostatin analogue, reduces myointimal hyperplasia after experimental balloon angioplasty when given subcutaneously. The feasibility and efficacy of a single dose of angiopeptin delivered locally via the Wolinsk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9403b3cf73b6bf1f7693f8786191539e
https://pubmed.ncbi.nlm.nih.gov/8101773
https://pubmed.ncbi.nlm.nih.gov/8101773
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals. 19(4)
The disposition and tissue distribution of angiopeptin, a long-acting octapeptide analogue of somatostatin, were studied in rats following single iv and sc administration of the drug. Similar plasma levels and excretion values of angiopeptin were obs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::76f882535482af5c01d8cf105c06266a
https://pubmed.ncbi.nlm.nih.gov/1680648
https://pubmed.ncbi.nlm.nih.gov/1680648
Autor:
Cathapermal S; Department of Physiology and Biophysics, Georgetown University Medical Center, Washington, DC 20007, USA., Lavigne MC, Leong-Son M, Alibadi T, Ramwell PW
Publikováno v:
Journal of cardiovascular pharmacology [J Cardiovasc Pharmacol] 1998 Apr; Vol. 31 (4), pp. 499-505.
Autor:
Vargas R; Department of Physiology and Biophysics, Georgetown University Medical Center, Washington, DC 20007, USA., Wroblewska B, Rego A, Cathapermal S, Ramwell PW
Publikováno v:
Journal of cardiovascular pharmacology [J Cardiovasc Pharmacol] 1997 Feb; Vol. 29 (2), pp. 278-83.
Autor:
Farhat MY; Department of Physiology and Biophysics, Georgetown University Medical Center, Washington, D.C. 20007., Chen MF, Bhatti T, Iqbal A, Cathapermal S, Ramwell PW
Publikováno v:
British journal of pharmacology [Br J Pharmacol] 1993 Oct; Vol. 110 (2), pp. 719-23.
Autor:
Leszczynski D; Department of Surgery, Georgetown University Medical Center, Washington, DC., Zhao Y, Cathapermal S, Nilsson J, Foegh ML
Publikováno v:
Life sciences [Life Sci] 1993; Vol. 53 (22), pp. 1663-74.
Autor:
Thomas G; Department of Physiology and Biophysics, Georgetown University Medical Center, Washington, District of Columbia., Myers A, Farhat M, Cathapermal S, Ramwell PW
Publikováno v:
The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 1992 Jun; Vol. 261 (3), pp. 875-8.
Autor:
Rego A; Department of Physiology and Biophysics, Georgetown University Medical Center, Washington, DC., Vargas R, Cathapermal S, Kuwahara M, Foegh ML, Ramwell PW
Publikováno v:
The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 1991 Nov; Vol. 259 (2), pp. 905-15.
Autor:
Cathapermal S, Caddy B
Publikováno v:
The Analyst [Analyst] 1988 Mar; Vol. 113 (3), pp. 385-8.